Advertisement
GMED vs PAVM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a Hold and PAVM is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GMED’s FA Score shows that 0 FA rating(s) are green whilePAVM’s FA Score has 0 green FA rating(s).
- GMED’s FA Score: 0 green, 5 red.
- PAVM’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GMED’s TA Score shows that 6 TA indicator(s) are bullish while PAVM’s TA Score has 6 bullish TA indicator(s).
- GMED’s TA Score: 6 bullish, 4 bearish.
- PAVM’s TA Score: 6 bullish, 4 bearish.
Price Growth
GMED (@Medical/Nursing Services) experienced а -1.05% price change this week, while PAVM (@Medical/Nursing Services) price change was +8.57% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.47%. For the same industry, the average monthly price growth was -8.60%, and the average quarterly price growth was +8.79%.
Reported Earning Dates
GMED is expected to report earnings on Feb 19, 2026.
Industries' Descriptions
@Medical/Nursing Services (-5.47% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| GMED | PAVM | GMED / PAVM | |
| Capitalization | 11.2B | 10.6M | 105,660% |
| EBITDA | 620M | 68.6M | 904% |
| Gain YTD | 1.342 | -38.765 | -3% |
| P/E Ratio | 27.00 | 0.09 | 31,330% |
| Revenue | 2.63B | 1.02M | 257,451% |
| Total Cash | 229M | 4M | 5,719% |
| Total Debt | 121M | 9.31M | 1,300% |
GMED | PAVM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 80 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 76 Overvalued | 95 Overvalued | |
PROFIT vs RISK RATING 1..100 | 55 | 100 | |
SMR RATING 1..100 | 72 | 100 | |
PRICE GROWTH RATING 1..100 | 38 | 89 | |
P/E GROWTH RATING 1..100 | 99 | 100 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GMED's Valuation (76) in the Medical Specialties industry is in the same range as PAVM (95). This means that GMED’s stock grew similarly to PAVM’s over the last 12 months.
GMED's Profit vs Risk Rating (55) in the Medical Specialties industry is somewhat better than the same rating for PAVM (100). This means that GMED’s stock grew somewhat faster than PAVM’s over the last 12 months.
GMED's SMR Rating (72) in the Medical Specialties industry is in the same range as PAVM (100). This means that GMED’s stock grew similarly to PAVM’s over the last 12 months.
GMED's Price Growth Rating (38) in the Medical Specialties industry is somewhat better than the same rating for PAVM (89). This means that GMED’s stock grew somewhat faster than PAVM’s over the last 12 months.
GMED's P/E Growth Rating (99) in the Medical Specialties industry is in the same range as PAVM (100). This means that GMED’s stock grew similarly to PAVM’s over the last 12 months.
| GMED | PAVM | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 75% | 2 days ago 80% |
| Stochastic ODDS (%) | 2 days ago 64% | 2 days ago 86% |
| Momentum ODDS (%) | 2 days ago 69% | 2 days ago 87% |
| MACD ODDS (%) | 2 days ago 72% | 2 days ago 84% |
| TrendWeek ODDS (%) | 2 days ago 58% | 2 days ago 84% |
| TrendMonth ODDS (%) | 2 days ago 60% | 2 days ago 90% |
| Advances ODDS (%) | 10 days ago 65% | 8 days ago 85% |
| Declines ODDS (%) | 2 days ago 59% | 6 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 67% | 2 days ago 81% |
| Aroon ODDS (%) | 2 days ago 52% | 2 days ago 90% |
Advertisement
PAVM and
Correlation & Price change
A.I.dvisor tells us that PAVM and GMED have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PAVM and GMED's prices will move in lockstep.
| Ticker / NAME | Correlation To PAVM | 1D Price Change % | ||
|---|---|---|---|---|
| PAVM | 100% | +1.12% | ||
| GMED - PAVM | 26% Poorly correlated | +0.48% | ||
| CVRX - PAVM | 25% Poorly correlated | -0.92% | ||
| ESTA - PAVM | 25% Poorly correlated | +3.52% | ||
| RVTY - PAVM | 25% Poorly correlated | -0.87% | ||
| CSTL - PAVM | 24% Poorly correlated | +3.28% | ||
More | ||||